Rainbow Childrens Medicare Results Earnings Call for Q2FY24
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.31-10-2023
Rainbow Childrens Medicare Results Earnings Call for Q2FY24
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Earnings presentation on Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on un-audited financial results(Standalone & Consolidated) for the quarter and half year ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring agency report for the quarter ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Statement Of Deviation Or Variation In Utilisation Of Funds Raised Though Initial Public Offer For The Quarter Ended September 30, 2023
Statement of Deviation or variation in utilisation of funds raised through Initial Public Offer for the quarter ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Mr. Aluri Srinivasa Rao as an Independent Director of the CompanyRainbow Children's Medicare Ltd - 543524 - Board Meeting Outcome for Outcome Of The Board Meeting Held On October 30, 2023.
Un-Audited Financial Results for the quarter and half year ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2023
Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2023Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings call- Q2 & H1 FY 24Rainbow Children's Medicare Ltd - 543524 - Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023
Rainbow Children''s Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 ,inter alia, to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the Company for the Quarter and Half Year ended September 30, 2023.